Inhibitory effects of AG490 on H2O2-induced TRPM2-mediated Ca(2+) entry

Eur J Pharmacol. 2014 Nov 5:742:22-30. doi: 10.1016/j.ejphar.2014.08.023. Epub 2014 Aug 30.

Abstract

Transient receptor potential melastatin 2 (TRPM2) is an oxidative stress-sensitive Ca(2+)-permeable channel that controls Ca(2+) signalling. The activation of Janus kinase 2 (Jak2) by oxidative stress is implicated in the production of inflammatory mediators. We found that AG490, a Jak2 inhibitor, had an inhibitory effect on H2O2-induced TRPM2 activation. The purpose of this study was to examine the underlying mechanisms of the inhibitory effects of AG490. Activation of TRPM2 in TRPM2-expressing human embryonic kidney 293 (TRPM2/HEK) cells or the human monocytic cell line U937 was monitored by fluorescence-based Ca(2+) imaging and patch-clamp techniques. Treatment with AG490 almost completely blocked H2O2-induced increase in intracellular Ca(2+) in TRPM2/HEK and U937 cells. In the patch-clamp study, AG490 inhibited the H2O2-evoked inward current but not the ADP-ribose-induced inward current in TRPM2/HEK cells. In contrast, Jak inhibitor 1 (pyridone 6) and staurosporine, both of which inhibit Jak2, had no effect on H2O2-induced increase in intracellular Ca(2+). Moreover, AG490 decreased intracellular reactive oxygen species level, which was measured by using a hydroperoxide-sensitive fluorescent dye, on incubation with H2O2. In the cell-free assay system, AG490 scavenged hydroxyl radicals but not H2O2. These findings indicate that AG490 significantly reduces H2O2-induced TRPM2 activation, presumably by scavenging hydroxyl radicals rather than Jak2-dependent mechanisms. Although transient receptor potential ankyrin 1 (TRPA1) channel is also activated by H2O2, the H2O2-induced Ca(2+) entry through TRPA1 was only slightly delayed by AG490. This validates the potential use of AG490, as one of the materials for characterizing the role of TRPM2 channels in pathological models.

Keywords: AG490; Janus kinase 2; Oxidative stress; TRPA1; TRPM2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzimidazoles / pharmacology
  • Calcium Channels / metabolism
  • Calcium Signaling / drug effects*
  • Enzyme Inhibitors / pharmacology
  • Free Radical Scavengers / pharmacology
  • HEK293 Cells
  • Humans
  • Hydrogen Peroxide / toxicity*
  • Janus Kinase 1 / antagonists & inhibitors
  • Janus Kinase 2 / antagonists & inhibitors
  • Janus Kinase 2 / metabolism
  • Nerve Tissue Proteins / metabolism
  • Oxidative Stress / drug effects
  • Patch-Clamp Techniques
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Poly(ADP-ribose) Polymerases / metabolism
  • Pyridones / pharmacology
  • Reactive Oxygen Species / metabolism
  • Recombinant Proteins / metabolism
  • Staurosporine / pharmacology
  • TRPA1 Cation Channel
  • TRPM Cation Channels / agonists
  • TRPM Cation Channels / antagonists & inhibitors
  • TRPM Cation Channels / metabolism*
  • Transient Receptor Potential Channels / metabolism
  • Tyrphostins / pharmacology*
  • U937 Cells

Substances

  • 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one
  • Benzimidazoles
  • Calcium Channels
  • Enzyme Inhibitors
  • Free Radical Scavengers
  • Nerve Tissue Proteins
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Pyridones
  • Reactive Oxygen Species
  • Recombinant Proteins
  • TRPA1 Cation Channel
  • TRPA1 protein, human
  • TRPM Cation Channels
  • TRPM2 protein, human
  • Transient Receptor Potential Channels
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Hydrogen Peroxide
  • Poly(ADP-ribose) Polymerases
  • JAK1 protein, human
  • JAK2 protein, human
  • Janus Kinase 1
  • Janus Kinase 2
  • Staurosporine